Company Overview
CIMG Inc operates within the consumer defensive sector, specifically focusing on the packaged foods industry, which generally provides essential goods that maintain demand regardless of broader economic fluctuations. The company's core business involves the provision of consumer food and beverage products, including maca peptide coffee, noni, purified powder, and wine, which are distributed through wholesale channels such as grocery stores, convenience stores, and vending machine operators. This entity functions at a micro-cap scale with a total market capitalization of $3.45M and employs a workforce of 13 individuals. The annualized revenue generated over the trailing twelve months is $26.04M, a figure that, when combined with the minimal employee count, suggests a highly leveraged operational model or significant reliance on outsourced production and distribution networks. The disparity between the modest market cap and the substantial revenue base indicates that the market is currently pricing the company based on significant risk factors rather than traditional valuation metrics derived from profitability or asset base.
Financial Health
The company reported a revenue of $26.04M for the trailing twelve months, yet this top-line activity resulted in a net income of $-22,824,620 and an EBITDA of $-5,578,624. The substantial gap between the positive revenue figure and the large negative net income reveals a severe cost structure issue where operating expenses and cost of goods sold far exceed the revenue generated, driving the bottom line deeply into the red. Despite the negative earnings, the company maintains a positive free cash flow of $6.89M, which indicates that the business generates sufficient cash from operations after capital expenditures to provide a degree of financial flexibility for working capital needs or debt servicing. However, the financial position is underpinned by a cash balance of only $45,356 against a total debt load of $459,209, creating a precarious liquidity environment. The debt-to-equity ratio stands at 0.81, suggesting a leveraged balance sheet where liabilities approach the size of shareholder equity, while the current ratio of 0.32 indicates that current assets are insufficient to cover current liabilities without external financing or asset liquidation. Return on Equity is reported at -78.9% and Return on Assets at -9.7%, metrics that collectively reveal a management structure that has been unable to generate returns on capital deployed, resulting in a significant erosion of shareholder value and asset efficiency.
Valuation Assessment
The company presents with a trailing P/E ratio of N/A and a forward P/E ratio of N/A, implying that traditional earnings-based valuation models are inapplicable due to the absence of positive earnings and that the market does not expect immediate earnings normalization based on current data. The price-to-book ratio is listed at 0.06, which indicates that the company's market valuation is trading at a steep discount relative to its book value, suggesting a market perception of high distress or a lack of tangible asset backing at current market prices. Alternative valuation metrics further highlight the company's financial stress, as the price-to-sales ratio sits at 0.13 and the EV/EBITDA is negative at -0.50, reflecting a valuation that is disconnected from sales performance and profitability. Regarding trading range, the stock has fluctuated between a 52-week high of $13.84 and a 52-week low of $0.05, meaning the current trading price is significantly closer to the bottom of this range. The beta value is listed as N/A, which prevents a direct comparison of the stock's price volatility relative to the broader market, leaving the risk profile undefined by standard market sensitivity measures.
Growth & Income
The company reports a revenue growth year-over-year of 68901.0%, while the earnings growth year-over-year is N/A due to the lack of prior period earnings for comparison. This extreme revenue expansion without a corresponding historical earnings baseline suggests a one-time event, restatement, or initial listing adjustment rather than sustainable organic growth, and the absence of earnings growth data prevents an analysis of whether profitability is improving alongside sales. As a non-dividend payer, the company reports a dividend yield of N/A and a payout ratio of 0.0%, indicating that the firm retains all cash flow for operations rather than distributing income to shareholders. Consequently, the overall growth and income profile is characterized by massive, albeit unproven, revenue expansion that is not supported by current profitability or dividend distributions.